Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.33B.
ENTERPRISE VALUE (EV)
$1.33B
Immunome, Inc.
Market Cap
$1.98B
Enterprise Value (EV)
$1.33B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Immunome, Inc. (IMNM) | $1.98B | $1.33B |
| AxoGen, Inc. (AXGN)vs › | $2.00B | $1.92B |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.01B | $1.89B |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.02B | $1.92B |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.02B | $1.98B |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | $2.14B |
| Azenta, Inc. (AZTA)vs › | $2.03B | $1.90B |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | $2.29B |
| Alvotech (ALVO)vs › | $2.07B | $3.38B |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | $1.88B |
Market Cap
$1.98B
Total Debt
$3.85M
Cash
$653.48M
Enterprise Value
$1.33B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
